Albet C - Search Results

1

A bioavailability/bioequivalence and pharmacokinetic study of two oral doses of torasemide (5 and 10 mg): prolonged-release versus the conventional formulation.

Barbanoj MJ, Ballester MR, Antonijoan RM, Puntes M, Gropper S, Santos B, Albet C, Guglietta A. Barbanoj MJ, et al. Among authors: albet c. Clin Exp Pharmacol Physiol. 2009 May;36(5-6):469-77. doi: 10.1111/j.1440-1681.2008.05089.x. Epub 2008 Oct 8. Clin Exp Pharmacol Physiol. 2009. PMID: 19673928 Clinical Trial.

2

Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administration.

Farré M, Roset PN, Llorente M, Márquez M, Albet C, Pérez JA, Herrero E, Ortíz JA. Farré M, et al. Among authors: albet c. Methods Find Exp Clin Pharmacol. 1997 Jun;19(5):343-50. Methods Find Exp Clin Pharmacol. 1997. PMID: 9379783 Clinical Trial.

3

Decreased linezolid uptake in an in vitro-selected linezolid-resistant Staphylococcus epidermidis mutant.

Sierra JM, Ortega M, Tarragó C, Albet C, Vila J, Terencio J, Guglietta A. Sierra JM, et al. Among authors: albet c. J Antimicrob Chemother. 2009 Nov;64(5):990-2. doi: 10.1093/jac/dkp309. Epub 2009 Aug 27. J Antimicrob Chemother. 2009. PMID: 19717395

4

Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral doses.

Farré M, Roset PN, Badenas JM, Ugena B, Márquez M, Albet C, Herrero E, Ortiz JA. Farré M, et al. Among authors: albet c. Arzneimittelforschung. 1997 Apr;47(4A):528-30. Arzneimittelforschung. 1997. PMID: 9205758

5

Pharmacokinetic study of ebrotidine administered in multiple doses to healthy volunteers for 4 days.

Frías J, Esteban C, Carcas AJ, Sánchez-García P, Albet C, Torres J, Márquez M, Ortiz JA. Frías J, et al. Among authors: albet c. Arzneimittelforschung. 1997 Apr;47(4A):531-4. Arzneimittelforschung. 1997. PMID: 9205759 Clinical Trial.

6

Pharmacokinetics of Camonagrel in experimental animal: rat, rabbit and dog.

Albet C, Pérez A, Rozman E, Sacristan A, Ortiz JA. Albet C, et al. Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):251-4. doi: 10.1007/BF03189347. Eur J Drug Metab Pharmacokinet. 1998. PMID: 9725489

7

Pharmacokinetics of ebrotidine in healthy volunteers. A summary.

Albet C, Pérez JA, Rozman E, Márquez M, Herrero E, Ortiz JA. Albet C, et al. Arzneimittelforschung. 1997 Apr;47(4A):535-9. Arzneimittelforschung. 1997. PMID: 9205760 Clinical Trial.

8

Pharmacokinetics of ebrotidine in rats and dogs.

Albet C, Pérez JA, Sacristán A, Ortiz JA. Albet C, et al. Arzneimittelforschung. 1997 Apr;47(4A):483-5. Arzneimittelforschung. 1997. PMID: 9205748

9

Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists.

Martínez C, Albet C, Agúndez JA, Herrero E, Carrillo JA, Márquez M, Benítez J, Ortiz JA. Martínez C, et al. Among authors: albet c. Clin Pharmacol Ther. 1999 Apr;65(4):369-76. doi: 10.1016/S0009-9236(99)70129-3. Clin Pharmacol Ther. 1999. PMID: 10223772 Clinical Trial.

10

Determination of sertaconazole nitrate, a new imidazole antifungal, by high-performance liquid chromatography.

Albet C, Fernandez JM, Rozman E, Perez JA, Sacristan A, Ortiz JA. Albet C, et al. J Pharm Biomed Anal. 1992 Feb-Mar;10(2-3):205-11. doi: 10.1016/0731-7085(92)80030-q. J Pharm Biomed Anal. 1992. PMID: 1391101

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters